Acute Myelogenous Leukemia (AML) News and Updates

1 - 10 of 10

CHOP Researchers Win Science Center Award to Develop AML Treatment

CHOP Researchers Win Science Center Award to Develop AML Treatment

The $200,000 award will fund research to develop a novel therapeutic that ignites the immune system and could act as a stand-alone treatment, as well as boost the effectiveness of existing immunotherapies.

Read more

AML Immunotherapy Trial Opens

Published on in Oncology Update

CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.

CHOP AML Expert Featured in USA Today

Published on in CHOP News

Richard Aplenc, MD, an oncologist at The Children's Hospital of Philadelphia, discusses acute myeloid leukemia diagnosis and treatment in an article in USA Today.